Article

Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact’s work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Dr. Patel also discusses the importance of communication among pharmacy benefit managers, plan sponsors, and physicians as generic drug costs continue to rise.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Sundar Jagannath
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Senator Vincent Polistina (R, New Jersey)
1 expert in this video
Amir Fathi, MD, Mass General
Ayodeji Adegunsoye, MD, PhD, MSc
Karen Fernandez, MD
4 experts in this video
4 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo